![[Translate to English:]](/fileadmin/user_upload/Pressemitteilungen/Bilder/Software/Frost_Sullivan-Award-2019_Thumbnail_100x100.png "[Translate to English:]")
Lüneburg, Germany, 25 October 2019 – Based on its recent analysis of the global manufacturing execution system (MES) market for pharmaceuticals, biotechnology, and cell & gene therapies, Frost & Sullivan recognizes Werum IT Solutions with the 2019 Global MES for Pharmaceuticals, Biotechnology, and Cell & Gene Therapies Customer Value Leadership Award. Its MES solution, PAS-X, supports complex operations, higher productivity, and adherence to regulatory requirements. Its end-to-end solution comprises the PAS-X software product, pre-configured content for pharma and biotech processes, as well as consulting, training, and support services.
"Werum continuously innovates to deliver true value through market-leading solutions to create digital production processes. It has also developed an extensive ecosystem comprising warehouse management, finite scheduling, and track & trace serialization aggregation solutions for adjacent applications in pharmaceutical or biotech factories," said Shruti Singh, Industry Analyst, Frost & Sullivan. "In addition, Werum’s solutions greatly simplify the integration of machines, equipment, and automation systems into the existing production environment. Together with its customers, Werum creates the digital Pharma 4.0 factory of the future."
“Earning the prestigious Frost & Sullivan Customer Value Leadership Award is a tremendous achievement for which we are grateful,” said Jens Woehlbier, CEO of Werum IT Solutions GmbH. “We believe successful operation not only comes from best quality solutions but by understanding and exceeding customer expectations. Through our community-oriented approach – PAS-X users represent the largest pharma and biotech MES user community worldwide – we add value to our customers' operations and contribute to their effective and sustained success.”
PAS-X MES specifically enables pharma and biotech manufacturers to meet increasing quality and regulatory requirements through built-in data integrity. It also reduces the need for human intervention in pharma and biotech companies, thereby reducing errors. Werum's solution can help customers achieve return on investment in just two to three years. It aims to develop a continuously growing portfolio of new software products, features, and services, helping pharma, biotech, and cell & gene therapy manufacturers expand their businesses.
"The company delivers best-in-class service, helping customers engage optimally with its PAS-X solution. This software is used by the majority of the world's top 30 pharma and biotech companies and many mid-sized manufacturers in more than 1,000 installations," noted Singh. "With exceptional PAS-X quality and commitment to innovation, Werum offers outstanding customer value in MES."
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. The award recognizes the company's focus on augmenting the value that its customers receive, beyond simply good customer service, leading to improved customer retention and customer base expansion. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
